New Venture Fund for Communications

The New Venture Fund for Communications makes one-time, catalytic investments of $250,000 and less to raise awareness and increase knowledge of and engagement with global health, hunger, and poverty. The ultimate intent of the investment strategy is to support decision makers and targeted audiences in their efforts to address these issues.


Specifically, the New Venture Fund for Communications funds projects that support the following goals:


  • Raise awareness, knowledge, and engagement among decision makers and other targeted audiences on global health and development in the United Kingdom, United States, France, Germany, India, Nigeria, Kenya, and other parts of Sub-Saharan Africa. Priority issues include communications projects focused on development aid and issues facing the developing world, such as: agriculture; economic empowerment; family planning; infectious diseases (HIV, TB, malaria, polio); vaccine delivery; and reproductive, maternal, newborn, child, and adolescent health.
  • Support innovative communications and media projects that create, test, and share new measurement frameworks, tools, and research to increase the visibility of the issues listed above.


The New Venture Fund for Communications will also fund projects that aim to understand the proliferation of misinformation and its relationship to trust in the news media; and support efforts to make the media more trustworthy. This is a new, short-term funding priority. Grants awarded for this purpose should either:


  • Generate research about how information (and misinformation) spreads in the new media environment and potential solutions for fact-based information; or
  • Catalyze efforts to build audience trust, with a particular focus on diversity and inclusion.

This fund prioritizes grants to organizations with budgets under $5 million and funds projects with a duration of up to 12 months.


Grant seekers interested in applying for a grant from the New Venture Fund for Communications can click here.

1201 Connecticut Avenue NW, Suite 300, Washington, DC 20036 | 202-595-1061 | info[at]